In 2012, Calcivis was founded by CEO Adam Christie and CTO Bruce Vernon with a goal of revolutionizing oral health care through early detection and treatment of tooth decay. The company’s imaging system uses biological diagnostics to enable preventative treatment before tooth decay becomes irreversible.

Recently, Calcivis secured £5m funding led by Scottish National Investment Bank, which provided £4m, along with an additional £1m from IFS Maven Equity Finance managed by Maven Capital Partners. This investment will allow the company to bring its flagship product to the US market following FDA premarket approval.

Paul Callaghan, investment director of the Scottish National Investment Bank, praised Calcivis for its cutting-edge technology that improves health and well-being. He expressed pride in supporting the company’s expansion into international markets, creating employment opportunities in Scotland. The bank sees Calcivis’ technology as aligned with its innovation mission and foresees significant health benefits for people in Scotland from the product’s launch in the UK.

Adam Christie emphasized the importance of early diagnosis and treatment of caries, highlighting the potential of technology to revolutionize preventive oral health care. The World Health Organization reports that tooth decay affects more than two billion people worldwide, underscoring the need for innovative solutions like Calcivis.

By Samantha Johnson

As a dedicated content writer at, I immerse myself in the art of storytelling through words. With a keen eye for detail and a passion for crafting engaging narratives, I strive to captivate our audience with each piece I create. Whether I'm covering breaking news, delving into feature articles, or exploring thought-provoking editorials, my goal remains constant: to inform, entertain, and inspire through the power of writing. Join me on this journalistic journey as we navigate through the ever-evolving media landscape together.

Leave a Reply